Europe Hemophilia Market and Competitive Landscape - 2017

  • ID: 4377620
  • Report
  • Region: Europe
  • Fore Pharma
1 of 3
The latest research, Europe Hemophilia Market and Competitive Landscape - 2017, provides comprehensive insights into Hemophilia pipeline, epidemiology, market valuations, product sales, market forecast, product forecasts, and market shares. This study accurately estimates and forecast Hemophilia market size and drug sales. This research also provides insights into Hemophilia epidemiology and late stage pipeline.

The report is classified into nine sections - Hemophilia overview with definitions, symptoms, etiology, diagnosis, treatment options; Hemophilia pipeline insights covering late stage clinical trials pipeline; Hemophilia prevalence trends by countries; Hemophilia market size and forecast by countries, market events, trends; product sales and forecast by countries; market shares by countries. The research scope includes EU5 countries - Germany, France, Italy, Spain, UK, Europe.

Research Scope:
  • Hemophilia pipeline: Find out the drugs in clinical trials for Hemophilia by stages, phase 3 clinical trials, phase 2 clinical trials, and phase 1 clinical trials, by pharmacological class, by company
  • Hemophilia epidemiology: Find out the prevalence of Hemophilia by countries - Europe, Germany, France, Italy, Spain, UK, Japan; prevalence forecast to 2025
  • Hemophilia products: Identify key products marketed and prescribed for Hemophilia by brand name, by molecule, by company, by branded / generic, by countries - Europe, Germany, France, Italy, Spain, UK, Japan
  • Hemophilia market size: Find out the market size for Hemophilia drugs by countries - Europe, Germany, France, Italy, Spain, UK, Japan; Find out how the market advanced from 2012
  • Hemophilia drug sales: Find out the sales of Hemophilia drugs by countries - Europe, Germany, France, Italy, Spain, UK
  • Hemophilia drugs sales forecast: Sales forecast for Hemophilia drugs to 2021 by countries - Europe, Germany, France, Italy, Spain, UK, Japan
  • Hemophilia market share analysis: Find out the market shares of Hemophilia drugs and outlook by countries - Europe, Germany, France, Italy, Spain, UK, Japan
Benefits of this Research: The research helps executives to
  • Evaluate commercial market opportunities for Hemophilia drugs
  • Synthesize insights for business development & licensing
  • Track market size, competitor drug sales, market shares in Hemophilia market
  • Develop in-depth knowledge of competition and markets
  • Analyze sales data to update your brand planning trackers
  • Develop tactics and strategies to take advantage of opportunities in the market
  • Track market trends and analyze key events in Hemophilia market
  • Develop forecast models, healthcare frameworks, or economic models
  • Answer key business questions; supports decision making in R&D to long term marketing strategies


This report will take 1-2 business days to deliver.
READ MORE
Note: Product cover images may vary from those shown
2 of 3
1. Hemophilia: Disease Overview
1.1. Hemophilia Symptoms
1.2. Hemophilia Etiology
1.3. Hemophilia Diagnosis
1.4. Hemophilia Treatment Options

2. Hemophilia Pipeline Insights
2.1. Hemophilia Phase 3 Clinical Trials
2.2. Hemophilia Phase 2 Clinical Trials
2.3. Hemophilia Phase 1 Clinical Trials

3. Hemophilia Epidemiology Analysis

4. Germany Hemophilia Market Insights
4.1. Marketed Products for Hemophilia in Germany
4.2. Germany Hemophilia Market Size & Forecast
4.3. Germany Hemophilia Product Sales Forecast
4.4. Germany Hemophilia Market Share Analysis

5. France Hemophilia Market Insights
5.1. Marketed Products for Hemophilia in France
5.2. France Hemophilia Market Size & Forecast
5.3. France Hemophilia Product Sales Forecast
5.4. France Hemophilia Market Share Analysis

6. Italy Hemophilia Market Insights
6.1. Marketed Products for Hemophilia in Italy
6.2. Italy Hemophilia Market Size & Forecast
6.3. Italy Hemophilia Product Sales Forecast
6.4. Italy Hemophilia Market Share Analysis

7. Spain Hemophilia Market Insights
7.1. Marketed Products for Hemophilia in Spain
7.2. Spain Hemophilia Market Size & Forecast
7.3. Spain Hemophilia Product Sales Forecast
7.4. Spain Hemophilia Market Share Analysis

8. UK Hemophilia Market Insights
8.1. Marketed Products for Hemophilia in UK
8.2. UK Hemophilia Market Size & Forecast
8.3. UK Hemophilia Product Sales Forecast
8.4. UK Hemophilia Market Share Analysis

9. Europe Hemophilia Market Insights
9.1. Europe Hemophilia Market Size & Forecast
9.2. Europe Hemophilia Product Sales Forecast
9.3. Europe Hemophilia Market Share Analysis

10. Research Methodology

List of Tables:
Table 1: Hemophilia Phase 3 Clinical Trials, Global, 2017
Table 2: Hemophilia Phase 2 Clinical Trials, Global, 2017
Table 3: Hemophilia Phase 1 Clinical Trials, Global, 2017
Table 4: Hemophilia Prevalence by EU5 Countries, 2012 - 2021
Table 5: Marketed Products for Hemophilia in Germany, 2017
Table 6: Germany Hemophilia Market Size & Forecast ($mn), 2012 - 2021
Table 7: Germany Hemophilia Product Sales ($mn), 2012 - 2021
Table 8: Germany Hemophilia Market Trends, 2012 - 2021
Table 9: Marketed Products for Hemophilia in France, 2017
Table 10: France Hemophilia Market Size & Forecast ($mn), 2012 - 2021
Table 11: France Hemophilia Product Sales ($mn), 2012 - 2021
Table 12: France Hemophilia Market Trends, 2012 - 2021
Table 13: Marketed Products for Hemophilia in Italy, 2017
Table 14: Italy Hemophilia Market Size & Forecast ($mn), 2012 - 2021
Table 15: Italy Hemophilia Product Sales ($mn), 2012 - 2021
Table 16: Italy Hemophilia Market Trends, 2012 - 2021
Table 17: Marketed Products for Hemophilia in Spain, 2017
Table 18: Spain Hemophilia Market Size & Forecast ($mn), 2012 - 2021
Table 19: Spain Hemophilia Product Sales ($mn), 2012 - 2021
Table 20: Spain Hemophilia Market Trends, 2012 - 2021
Table 21: Marketed Products for Hemophilia in UK, 2017
Table 22: UK Hemophilia Market Size & Forecast ($mn), 2012 - 2021
Table 23: UK Hemophilia Product Sales ($mn), 2012 - 2021
Table 24: UK Hemophilia Market Trends, 2012 - 2021
Table 25: Europe Hemophilia Market Size & Forecast ($mn), 2012 - 2021
Table 26: Europe Hemophilia Product Sales ($mn), 2012 - 2021

List of Figures:
Figure 1: Hemophilia Pipeline by Phase (%), Global, 2017
Figure 2: Hemophilia Prevalence by EU5 Countries, 2012 - 2021
Figure 3: Germany Hemophilia Market Size ($mn), 2012 - 2021
Figure 4: Germany Hemophilia Product Sales ($mn), 2012 - 2021
Figure 5: Germany Hemophilia Market Share by Products (%), 2016
Figure 6: Germany Hemophilia Market - Future Market Share (%), 2021
Figure 7: France Hemophilia Market Size ($mn), 2012 - 2021
Figure 8: France Hemophilia Product Sales ($mn), 2012 - 2021
Figure 9: France Hemophilia Market Share by Products (%), 2016
Figure 10: France Hemophilia Market - Future Market Share (%), 2021
Figure 11: Italy Hemophilia Market Size ($mn), 2012 - 2021
Figure 12: Italy Hemophilia Product Sales ($mn), 2012 - 2021
Figure 13: Italy Hemophilia Market Share by Products (%), 2016
Figure 14: Italy Hemophilia Market - Future Market Share (%), 2021
Figure 15: Spain Hemophilia Market Size ($mn), 2012 - 2021
Figure 16: Spain Hemophilia Product Sales ($mn), 2012 - 2021
Figure 17: Spain Hemophilia Market Share by Products (%), 2016
Figure 18: Spain Hemophilia Market - Future Market Share (%), 2021
Figure 19: UK Hemophilia Market Size ($mn), 2012 - 2021
Figure 20: UK Hemophilia Product Sales ($mn), 2012 - 2021
Figure 21: UK Hemophilia Market Share by Products (%), 2016
Figure 22: UK Hemophilia Market - Future Market Share (%), 2021
Figure 23: Europe Hemophilia Market Size ($mn), 2012 - 2021
Figure 24: Europe Hemophilia Product Sales ($mn), 2012 - 2021
Figure 25: Europe Hemophilia Market Share by Products (%), 2016
Figure 26: Europe Hemophilia Market - Future Market Share (%), 2021
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
Note: Product cover images may vary from those shown
Adroll
adroll